- AGIO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $107.1 million.
- AGIO has traded 53,034 shares today.
- AGIO is down 4.1% today.
- AGIO was up 14.5% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in AGIO with the Ticky from Trade-Ideas. See the FREE profile for AGIO NOW at Trade-Ideas More details on AGIO: Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Currently there are 2 analysts that rate Agios Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Agios Pharmaceuticals has been 709,800 shares per day over the past 30 days. Agios has a market cap of $2.9 billion and is part of the health care sector and drugs industry. Shares are up 249.9% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.